Professor Mark Beresford

Professor Mark Beresford

MA BM Bch MRCP FRCR DM

Oncology

27 years of experience
16 years as a specialist

Subspecialties

  • Bladder Cancer
  • Brain Cancer
  • Breast Cancer
  • Clinical Oncology
  • Prostate Cancer
  • Renal Cancer
Show more

Languages spoken

  • English
Show more

Registered with

  • General Medical Council: 4213976
Show more

    Practices worked at

    Spire Bristol Hospital

    Redland Hill Durdham Down, Bristol, United Kingdom, BS6 6UT
    71 reviews

    Bath Clinic

    Claverton Down Road, Bath, United Kingdom, BA2 7BR
    37 reviews

    GenesisCare Bristol

    300 Park Ave, Bristol, United Kingdom, BS32 4SY
    18 reviews

    About

    Professor Mark Beresford is a Consultant Clinical Oncologist working at the Royal United Hospital Bath, specialising in breast and urological malignancies.

    Professor Beresford undertook his initial medical training at Gonville and Caius College, Cambridge University (1989-1992) before moving on to Oxford University for clinical training (1992-1995). Mark then moved to London for his junior doctor and specialist oncology training at St Mary’s, University College, Charing Cross and Mount Vernon Hospitals. His passion for medical research led him to receive a Doctorate of Medicine from Oxford University for research into predicting response to chemotherapy in breast cancer and was awarded the Frank Doyle Medal for the highest mark in the Royal College of Radiologists oncology fellowship exams; a trajectory of excellence he has continued on throughout his career.

    Mark was appointed as a consultant in oncology at University Hospital Bristol in 2006, moving his NHS practice to Royal United Hospital Bath in 2011. He is active in clinical research at a national level, being principal investigator on many trials and an active member of the National Cancer Research Institute Breast Cancer Clinical Studies Group since 2010. He is an Honorary Senior Lecturer at Bristol University and Visiting Researcher at Bath University and has been awarded grants for local clinical trials. He is particularly interested in methods for early assessment of benefit from treatment.

    Mark has advised NICE on the adoption and appraisal of new chemotherapy drugs, is a committee member of the British Uro-oncology Group and the Penny Brohn complimentary therapy centre. He is also a member of Innovators in Breast Cancer and Action for Bladder Cancer groups. He has personally authored over 50 scientific journal articles, conference posters and textbook chapters. Professor Beresford is renowned in his field and there are few better qualified clinicians to see patients in private practice.


    Diseases, Medical Tests and Treatments
    • Chemotherapy
    • Radiotherapy
    • Breast cancer
    • Kidney (renal) cancer
    • Prostate disease including prostate cancer
    • Urological oncology
    • Bladder cancer
    • Brain tumours

    Procedures

    • Chemotherapy
    • Hormone Therapy
    • Intensity Modulated Radiotherapy (IMRT)
    • Radiotherapy
    • RapidArc or Volume Modulated Arc Therapy (VMAT)
    • Stereotactic Ablative Radiotherapy (SABR)
    • Video Consultation
    Read more

    Special interests

    • Bladder Cancer
    • Brain Cancer
    • Brain Tumours
    • Breast Cancer
    • Prostate Cancer
    • Renal (Kidney) Cancer
    • Renal Cancer
    Read more

    Education

    • MA Cambridge University 1992
    • BM Bch Oxford University 1995
    • MRCP London 1998
    • FRCR London 2003
    • DM Oxford University 2008

    Memberships:

    • British Uro-oncology Group committee member
    • Action for Bladder Cancer committee member
    Read more
    This specialist has not collected any Doctify reviews